Thank you for downloading and welcome to Take Orally, the emergency medicine podcast recorded at Dream, Queen's Medical Centre, Nottingham. In this episode, we'll be discussing acute coronary syndrome. As ever, all information is correct at the time of recording. Any guidelines mentioned are correct for Nottingham University Hospital's NHS Trust. Other trust guidelines may vary. All views and opinions are the speaker's own. Hello, my name is Jamie and I'm one of the teaching fellows in emergency medicine. My name is Craig Douglas. I'm one of the consultants in emergency medicine at Queen's Medical Centre.
So, Craig, working in the emergency department, I don't think a day goes by when there isn't at least one patient for me to clarify who presents as chest pain. And I suppose the key differential to think about is acute coronary syndrome, ACS. So the first question is, what exactly is ACS and what is it not? Okay, yeah, good question. Well, the first thing I suppose I'd like to say is you're absolutely right. Obviously, working in the emergency department, we see a huge number of patients coming in with undifferentiated chest pain. It's probably our second most common presenting complaint.
And if you review the literature, we have a fairly good idea that about 10% of the patients that we see who come in with chest pain will go on to have a diagnosis of ACS or acute coronary syndrome. What exactly is ACS? Well, I mean, that is a spectrum of disease really that ranges through from unstable angina through a non-ST elevation MI through to an ST elevation MI. And I suppose I would define unstable angina as ischemic pain that's more severe. frequent or prolonged than normal, particularly pain that's lasting longer than 15 minutes, pain occurring with little or no exertion, pain that's associated with significant nausea, vomiting, marked sweating or breathlessness, or someone who's hemodynamically stable. These are things that shouldn't happen with somebody who has a stable cardiac diagnosis. And then in terms of the patients who actually have myocardial infarction, these are patients who have ischemic symptoms with actual evidence of myocardial necrosis.
And for us, that essentially means that they have a raised tribolin level. And then also you've got STEMI at the other end, which we'll get on into the end, as well as all of that with the classic ST elevation picture. Sure. Yeah, absolutely. Okay. So...
That's what ACS is and what it isn't so stable. I forgot the second part of your question there. What is it not? We talked about 10% of the chest pain that we see will be ACS. It's everything else. That's going to be quite a heterogeneous group. There's going to be a significant number of patients there who do have very significant disease urgent diagnoses to make your patients coming in with pulmonary embolism, aortic dissection, pneumothorax, pneumonia. That's going to form.
a significant part, but probably the larger proportion of your patients are those who come in with non-urgent diagnoses. These will be patients with reflux, dysbepsia, musculoskeletal chest pain, pericarditis. So it's going to be a heterogeneous group of patients, yeah. Okay. So, you know, you're exhausted in charge of polluting, which is majors in our emergency departments. So, you know, F1 of yours has gone off to Clark patient, you've seen on the screen, they're in with query ACS.
What are the key questions you would want that F1 to have asked the patient before they come in and report back to you? Okay, so there's nothing real rocket science about this. The history taken will pretty much take on the standard structure that the F1 will be used to having come through medical school. I suppose... I'd like them to have been able to take a good history of the pain. And I suppose the mnemonic Socrates is probably well known to most. But it's really important. Socrates, for those who don't know, stands for sight, onset, character, radiation, associated symptoms, time course of the pain, exacerbating and relieving features and severity. And that's a lot of useful information there.
You're also going to want to know about the past medical history, particularly when you're trying to find out about risk factors for underlying coronary artery disease. Medications will be useful to know about as well, particularly when you're planning what treatment you may be wanting to give, and obviously allergies falls into that same bracket. From the same point of view of wanting to know about cardiac risk factors, smoking is going to be important, alcohol is going to be important, and family history of premature coronary artery disease is going to be another key question. I suppose that the caveat that I would add to this is that...
These features are all important when they're taken together. It's very difficult. Just isolating them one feature at a time doesn't particularly alter your probability of whether you have acute coronary syndrome or not. It's when you take everything together between the history, patient's age, their risk factors, and then also what you see on their investigations, which we'll get on to, I'm sure, a bit later. It's really going to alter your perception of how likely it is that the patient in front of you has acute coronary syndrome or not. So you want all of those key bits all together.
Yeah, absolutely. It's about taking all that information. Just to give you an example, for instance, if you were just looking at the character of pain as a clue as to whether that patient has acute coronary syndrome or not. it's very difficult to glean any meaningful information. There's some work done by a quite prominent emergency consultant in Manchester called Rick Boldy, who was doing his PhD work a few years ago now, basically showing that, you know, I think the overall incidence of patients with MI in his undifferentiated chest pain population he was looking at was about 16%. And patients who came in with the sort of classical, sort of heavy, crushing central chest pain, their incidence was about 22%. But also the patients who came in sort of describing classical indigestion, their incidence, or their prevalence, sorry, of...
of MI was also 22%, so it made no difference. Just looking at that one factor does not significantly alter your probability of having a CS at the end of the day, but all the information taken together are put into part of a scoring system, and that can be really useful. And I suppose, like you said, taking the history, but also looking at its relevancy as well, I suppose, and so many... Patients who may be a query AC-SOI clerk, or I see, so they might be a gentleman in their 40s, that risk age group must say any family history of heart disease, and they'll say, oh yes, my father in their 90s had a heart attack, and you watch him, maybe one more of that, any younger people developing it. Yeah, absolutely, I think that is important information to know. I mean, so we just sort of touched that about the sort of character of the pain, and you know, very often hear the term cardiac-sounding chest pain, and I'm quite guilty about using that as well in some of my S-files and things. What does that mean to you, and what is cardiac-sounding chest pain? Well, it's an interesting term, really, isn't it?
I think you can talk about classical angina pain. For me, that's any real pain or discomfort in the front of the chest, the neck, the shoulders, the jaw, the arms, that's precipitated by physical exertion and relieved by rest after five minutes or so. I think you can talk about classical angina pain in that way. But as we touched on earlier, it's very difficult and quite dangerous to use the character of the pain as a discriminating feature in the patient that's coming into you with an undifferentiated acute onset of chest pain because we know that...
a large number of patients who go on to have an ACS diagnosis present what you might call sort of atypically, not with the classical central crushing chest pain. Particularly elderly patients, diabetic patients, female patients, they often present without that sort of classical central heavy crushing chest pain. So I think we need to be very careful just in terms of putting too much emphasis on the character of the pain. It's interesting, again, I can go back to some work from Manchester, I think. Some of the things that they noted were actually associated with a significantly increased likelihood of having MI or ACS. If you come in with chest pain and you're vomiting, you've got about a 40% chance of actually having an MI or some description. If you come in with chest pain and you're sweating heavily, actually it's more than a 50% chance of having an MI. Regardless of what the pain is like. Exactly. It's interesting that the vomiting and the sweating seem a bit more important there than the actual character of the pain itself.
There was also a systemic review published in JAMA last year from an American group, and they were looking at specific findings, specific risk factors from your clinical history and exam, and what made you more suggestive of having an acute coronary syndrome. So they presented their findings in terms of likelihood ratios. We're listeners. I think they might need a bit of a recap on likelihood ratios. In simple terms, you have a pre-test probability of having a diagnosis. So, for instance, we're chatting about our undifferentiated chest pain population. We know that 10% of those patients are going to have ACS, so you can say that's their pre-test probability, if you like. So likelihood ratio will give you a sort of...
multiplication, if you like, of how likely, if they have a specific feature of them actually having the condition. And I think what they came up with from the systemic review last year was that actually one of the things from history is that pain radiating to both arms was more significantly associated with the final diagnosis of acute coronary syndrome that had a likelihood ratio of just over two and a half. Just quite significant, certainly something that would get you thinking, you know, if that's the sort of pain that's being described to you. But actually, the take-home message from that particular study was that... individual factors taken on their own they don't cause a huge jump in the likelihood or not of developing UCS but as we come on to ensure information taken together as part of a risk stratification score is much more powerful data. I know that I speak to my students and regularly do and you say so you know what is cardiac chest pain they will say the classic it feels like somebody sits on your chest you sweat you feel sick you may vomit it goes to the left arm it's to the left jaw tingling in the left hand.
I think we've all got the anecdotes. I've seen a chap with an ST elevation MI where the pain was purely in the mouth. Just the other week, a chap with indigestion pain coming in, I've got indigestion, and it was an end-semi. I'm sure you've got similar anecdotes. Absolutely. And I suppose one of the take-home messages would be that any patient that comes in with acute onset pain in the chest, the neck, the shoulders, the jaw, and you don't have...
an alternative explanation for that pain, you've got to think ACS. You've got to think ACS until you're happy that it's not. I suppose that would be one of the take-homes. I mean, I remember when I was in F1 and doing an MEAU shift and a lot of patients in their 40s with chest pain, and I mentioned gourd as a differential, and my consultant looked at me with not very good look and said, you cannot put down gourd to a gentleman in their 40s and 50s with no previous dyspeptic history, no Barrett's esophagus, he's never been known to capture or had an endoscopy, you cannot put it down to gastritis without ruling out things like... ACS, you know, more serious life-threatening illness. Yeah, absolutely. I mean, that's one of the sort of ED maxims, really, is what is the worst possible diagnosis here? And how can I, you can never really exclude things 100%, no test is 100% sensitive, but how can I, as much as possible, rule out the worrying diagnosis that I do not want to miss?
So we've talked a bit there in the history, so just to reiterate, what's the biggest cardiac risk factors then, the things that you really need to have asked about in that history? Sure. I think the biggest cardiac risk factors are diabetes, smoking. dyslipidemia, hypertension, family history of the premature coronary artery disease, obesity and I think also to a certain extent have patients with peripheral arterial disease as well if you include that they are generalised vascular path and those would be the things I'd be definitely asking about as part of the history. Of course those patients with diabetes are at risk of that phenomenon as the silent MI are they? The silent MI or the atypical ACS presentation.
And these patients are much less likely to be diagnosed in the ED and their in-hospital mortality as a result is far greater than the patients who do present with the typical chest pain. So you really do need to have your wits about you with these patients. These patients will often present maybe just with shortness of breath or palpitations, generalized weakness, or a syncopal episode. These are all things with that history of diabetes where you need to have your mind engaged. You definitely need to be getting the ECG and giving that close scrutiny and considering about whether you need to be checking their markers of myocardial injury as well.
So I suppose we talked about that it's quite a small percentage of our patients coming in who actually do have ACS, and we mentioned some other potentially serious other differential diagnoses, such as pneumothorax dissection. So what features in the history might point away from a diagnosis of ACS? Okay, so I guess along those lines there, if we think about what are the diagnoses that we want to exclude, really? So the worrying diagnoses that we already sort of touched on in ACS, PE, dissection, pneumothorax, pneumonia. So there are features in the history that may point you towards one of those other worrying diagnoses. In terms of pulmonary embolism, does the patient in front of you actually have symptoms in keeping with a DBT? Do they have classical PE symptoms of that pleuritic chest pain and shortness of breath? Are there other risk factors for PE? Have they been immobilized recently? Have they had surgery within the last four weeks or so? Is there a history of previous venous thromboembolism with them?
Is there a history of active malignancy? Is there a patient who's coughing up blood in front of you? These are all things that might lead you down that line of inquiry. When it comes to thinking about dissection, there are two main groups of patients who end up with aortic dissection. You know, the first is your patients tend to be a little older with a history of hypertension, that sort of demographic. And then there's your younger patients who've got that history of connective tissue disease, your marathons, your Ehlers-Danlos, and that sort of thing. That might point you down that road. And then there's obviously that sort of classical ED teaching of chest pain plus one when you come to think about your aortic dissection. So, you know, is this someone who's presenting with chest pain plus something else? You know, whether that's symptoms in keeping with a stroke or a TIA or, you know, an ischemic limb or an ischemic gut.
or paralysis, you know, these are all things that can present in patients who are having a dissection as a result of that, you know, the pattern of the arteries that are being involved. So those would tend to pump you down that route. Your pneumothorax, obviously, maybe your younger smokers, you know, your tall skinny guys, your smokers, heavy cannabis users, or your older patients who've got that significant respiratory history, you know, maybe you think more about that as a diagnosis. And your pneumonias, you know, tends to obviously be your older patients for... in the majority of cases with fever, productive cough, that's going to take you down that road. Beyond that, there are going to be other features that are going to make you think more of a reflux disease or a pericarditis. We could go into those as well, but we'll probably be here all day. Hopefully that sort of answers your question about some of the other things you'd be thinking about, particularly when you're trying to rule out the other worrying diagnoses.
So those are the sort of questions you want the F1 you're working with to have thought about and to have asked and sort of the differentials that you want going through their head as well. I suppose before the F1 comes to you to sort of discuss the patient, what are the key investigations you've wanted to have taken place before you had that? I think when it comes to thinking about acute coronary syndromes, the two you really want are your ECG and your troponin level. Important to remember with the ECG, inpatients that go on to have a final diagnosis of ACS, as many as 40 to 60% of them will initially have a non-diagnostic ECG. So the fact that they may have a normal ECG first up...
by no means rills out the fact that they're having ACS but it is an important investigation obviously if you see something on there you know ST depression or other maybe less specific changes and that's you know you've got your diagnosis really but I think also important to remember the importance of doing serial ECGs particularly in your patient who remains symptomatic so doing serial ECGs and then as I say getting that troponin level as well is going to be really crucial. So I mean we'll talk about troponin in a little bit I suppose going back to the ECG. So SD elevation, MI, we're talking a bit as well, so that's to a bracket in itself, but think about an endosemi or an unstable angina, sort of ischemic ECG changes. What are they? What are the sort of things you look for? Okay, yeah, so I mean, you could talk all day about this, really, but in brief, the things that you want to be looking for...
In the very early stages, all that you might see in someone who's having a STEMI is sort of hyper-acute T-waves. So look for those sort of peak to tall T-waves. But then beyond that, obviously ST segment changes are the big one, whether that's elevation with people having a STEMI or ST depression in patients having an STEMI or acute coronary syndrome. T-wave inversions, obviously, new left bundle branch block. And indeed, in patients who have existing left bundle branch block.
You've got to think about things called the Skarbosa Criterion, which again, I don't expect F1s coming into the job to really know about, but it's certainly something that the senior clinician on their reviews is going to have to consider. I probably won't go into them in too much detail now. If people are interested, they can look them up online. Okay, so you've mentioned troponin. What is troponin? What is troponin?
So troponins, there are two main ones we look at, troponin I, troponin T. They're basically regulatory proteins which control the interaction of actin and myosin within cardiac myocytes. And when there is cardiac damage and damage to that myocyte cell membrane, then those proteins are released into the blitzer. And that's a blood test which has taken six hours following the chest pain. Well, I mean, where do you start with that? That's just a whole can of worms, really. At the moment in our department, yes, that's what we're doing. So we are using the standard, what's called a sensitive troponin measurement, which has been around for a long time. We're taking a level at six hours.
essentially excluding a non-STEMI in our patients with a query ACS. There are high sensitivity troponins now available and if you look at the sort of updated NICE guidance there are two high sensitivity troponins which they recommend if you do them at baseline and then a second sample at three hours. If those are negative then you can exclude them in STEMI based on those. So there's that sort of thing, but then there are also clinical scoring systems which incorporate a baseline.
normal sensitivity troponin into their risk stratification. And they're thinking more about acute coronary syndrome in general. So that includes your unstable angina patients. It's not limited to just your endstemi group. Okay. And what are those risk criteria called? Well, I suppose the one that I really like is the heart score, which was originally published in 2008 and has been validated first in 2013 since then.
And as I say, it's a risk stratification score for that undifferentiated chest pain population that come into ED. It looks at five main things. It looks at the history, risk factors, age of the patient, ECG findings, and a baseline troponin level. The score is from 0 to 10. Basically, patients who score very lowly, so in the sort of zero to three group, there's a less than 2% risk of those patients going on to have a major sort of adverse cardiac event within the next six weeks. So that would be patients having an MI, patients needing a PCI or a CABG or indeed dying as a result of a major cardiac event. So that's essentially your very low risk group that you should be able to send home from the emergency department. And then your high risk group sort of scoring seven to 10.
These are patients that have more than a 50% chance of going on to have one of these major adverse cardiac events within the next six weeks. There's clearly a group that you really need to focus on providing very aggressive coronary intervention. So I think before we go further, we've talked a bit about stable and unstable angina. We mentioned stable angina does not fall into ACS. So a patient with a known history of stable angina comes to you with chest pain. How would you discern through the history about that it might be an unstable angina?
Sure. So I think we sort of touched on elements of this already. So your unstable angina patient, as I say, that's going to be pain that's either more severe, more frequent, or more prolonged than normal. The sort of classical teaching is pain lasting for more than 15 minutes. As I say, pain that comes on with little or no exertion.
And then there's the other sort of associated features that I chatted about that you shouldn't really get with a stable angina picture. So that patient who's vomiting, that patient who's really sweaty or really breathless or comes in with a low blood pressure. I mean, these are features that you shouldn't be seeing with a stable angina. So it's going to make you think that there's something far more significant going on. I mean, when I'm clocking patients and they come in and this is a query ACS and they mention stable angina, I was trying to ask, you know, how stable is your stable angina? You know, is it a very predictable, I can walk?
a mile and I know I will get it and I take two sprays and I sit there for a minute and I know it will go away to get that kind of a picture into the mind of what is it like normally with this chronic condition and then to get an idea of how it might have changed to give you that idea. Yeah absolutely that's you know that's I think that's a really great lesson for for anyone who's thinking about how you take that history just you know really being able to get that clear in your mind what their normal pattern of disease is and then how things have changed today that's brought them understanding really what's brought them into hospital because they don't come into hospital every time they get an enzyme so just yeah getting that clear in your mind is going to be really key. So some of our listeners here will be getting that phone call when they're on call at 2 o'clock in the morning to come running to a ward that there's a patient who's suddenly developed chest pain and not looking very well with it and the nurses are concerned.
We see it in resus, the ambulance crew calling, we've got an active chest pain, they don't look well. So you've got a patient that's sat in front of you, the nurse is getting the monitoring on, what's the management plan, what are the priorities for sorting out our patient? Sure, okay. So if that sort of patient's in the emergency department, we're going to take them to the resus room. If that patient, as you say, is an F1 on the ward, you're not going to have that option really, but you do want to get some monitoring on them straight away. I think several things really need to be happening at the same time really with this sort of patient.
It's going to be important, as I say, that they get adequate monitoring on. You're going to want to start taking that history and examination for your patient so that you can start to form an idea of what you think is happening clinically. You're going to need an urgent ECG to see what's going on. Is this a patient having a STEMI in front of your eyes? Or are there other features of cardiac ischemia? Is it something else? You're going to need to get IV access pretty quickly, get your routine bloods taken off, including the troponin level. And then I think in terms of your basic...
management you know if this is someone you think is having an ischemic cardiac episode in front of you i think the old teaching used to be the mnemonic mona which is sort of morphine oxygen nitrates aspirin sort of gone away from that a little bit now it's we've lost the o from that the oxygen has has gone away and we had we had the avoid study back in 2013 which sort of basically showed in patients who were having a stemmy you know if they weren't hypoxic and you gave them sort of additional oxygen, which they didn't really need, then you increase their chances of having a recurrent MI or having quite a malignant dysrhythmia. So we've lost that oxygen for all patients unless, as I say, their oxygen saturations are below their target range. So for normal patients, if they've got sats 94 to 98, we're happy with that. And then for your sort of older chronic CO2 retainer, you're 88 to 92%. So apart from those patients, we don't tend to give oxygen now.
mainstays of treatment initially will be making sure you get that 300 milligrams of aspirin into them because that really does significantly decrease your chances of going on to have further sort of vascular events, and getting their pain controlled. Nitrates, obviously, is the first line, and then morphine, if you need to, for pain that is refractory. In the worst case scenarios, if your pain's still there, you'd better be thinking about nitrate infusions. So I suppose that would be the sort of initial management. Your further treatment, if you really think this is an acute coronary episode, can be guided a little bit about what you see on the ECG.
because obviously your treatment for STEMI is going to be very different for what you do for your patients with sort of NSTEMI slash unstable angina. Okay, so shall we talk a bit about STEMI then? So we'll go with the big one first. So you see ST elevation in the ECG. What do we do then? Well, you don't panic.
So you've already started to initiate treatment for your patient. The key thing is recognising the STEMI and then getting very quickly onto your friendly neighbourhood cardiologist. These are patients that need to go to the cath lab for PCI. The alternative treatment is thrombolysis for these patients, but it's been so long since a patient, certainly in this trust, has needed to stay here for thrombolysis. I couldn't even tell you when it was. All of our patients now go for PCI. Patients that go for PCI after their STEMI, their outcomes are across the board.
are much better, assuming that you can get them to the cath lab, sort of that door to skin time, less than 90 minutes. And, you know, in pretty much 100% of cases in this region, that is possible today. So the only additional thing that we would tend to do before they go for their PCI would be to give them a drug called Prasagrel, which is just a very strong platelet inhibitor. Like aspirin and clopidogrel. Yeah, like aspirin and clopidogrel, but it's got an even more powerful antiplatelet effect than clopidogrel does. The reason we don't tend to give that.
in the end STEMI pathway is that there are also increased bleeding risks with that particular drug. So it tends to be just used for patients with STEMI. I mean, I remember being, because I went to the University of Nottingham and I remember the consultants in cardiology teaching us, time is muscle with these patients. The longer they are in pain, that is muscle that is dying and your outcome is going to be worse and worse. And so it is a time-critical thing. I mean, certainly in this trust, patients who...
with the ambulance crew and show SC Elevation shouldn't come to our emergency pump and go elsewhere. I suppose there is that lesson there and also get to cross about because we've talked already, the serial ECGs, things change, don't they? And if your patient's having that prolonged period of chest pain that may be refractory to analgesia to make sure it has this turned into a STEMI, make sure you don't miss it. I mean, essentially. I mean...
There is that argument that STEMI is not really something that should be treated in the ED. There's very little that we can actually do, apart from trying to control the pain, getting some anti-plealics on boards. Those are patients that need to go and see a cardiologist as soon as possible. As you said, speak to the cardiologist as soon as possible, alert that the nurse is there. And if you have an off-site cat lab, if they're not in your hospital, that is a blue light transfer. Absolutely. 999, get this patient over as quickly as possible. Absolutely.
But also not forgetting a new left bundle branch block is also PCIable, isn't it? Sure. And also not to forget the posterior. Posterior STEMI, absolutely. And it does tend to catch people out as well, so important to remember that. And then the patient with ischemic symptoms that has ST depression in their anterior chest leads, got to think about a posterior STEMI, get the posterior chest leads on as well and look for ST elevation there.
And to people listening, I'm pointing to Life in the Fast Lane. It's a fantastic website, and their section in particular on posterior stenosis is brilliant. Not only how to read them, but also to take posterior chestlies, because it can be a bit tricky for some people, but not one to be missed. Yeah, absolutely. So Life in the Fast Lane is fantastic for all things emergency medicine-related, really. I suppose one of the other resources that direct you to from a cardiology standpoint is a chap called Amal Matu at the University of Maryland, who's really sort of ECG.
cardiology wizard. And he publishes a lot of really, really helpful things, helpful cases. And if you want to learn more about ECGs and acute coronary syndromes, it's worth checking out some of the stuff that he's done as well. He's an avid fan of Twitter as well. I do follow him because he's regularly on Twitter. Okay, so that's our semi-management. What about our own semi-management?
So again, we're seeing our patient who we suspect has ACS and no evidence of STEMI on their ECG. We're managing their ischemic pain with nitrates, and we've given them aspirin. I think when you get to that point, if you've got a patient who does have an ischemic-looking ECG, or you've got a positive baseline troponin back on them, or indeed just someone who's got a very high-risk history, then you're fine at that point going on and giving them clopidogrel, getting that sort of maximal antiplatelet effect, and giving them fondoparinux. as that sort of antithrombotic treatment, because really what you're trying to do for these patients is prevent further thrombosis in the coronary arteries. The caveat to that would be unless it is a patient who's got significant renal dysfunction, in which case you'd probably prefer to give them unfractionated heparin rather than von der Parneau.
For your patients who maybe are less sick, have a normal-looking ECG, maybe don't have a baseline troponin, they are stable and looking well, and maybe they don't really have that sort of real high-risk history, then I think it is perfectly reasonable for that group of patients to wait on their baseline troponin becoming available, wait on being able to do a GRACE risk stratification for them before you decide on whether they do need to go and have either clopidogrel or fondoparanox or even other things, you know, GEP2B3A inhibitors, all sorts of other medications that you might consider for this group. So you briefly mentioned a bit earlier about GTN infusion, and certainly this is something that I didn't know about until I started working in the emergency department. You do get that patient, you've given some GTN to, you're giving some aliquotsin for morphine to, but that pain is just not going away. And I think it's very useful if you're the F1C in these patients on the water, back in your mind, what's the next step? So can you talk a little bit about the GTN infusion, about how we set that up and where we go on from there?
how you set up, you kindly ask your cardiology nurse to set up for you. I mean, I think if you're on the ward with this sort of patient, you really need to be getting them to an area where you can provide sufficient monitoring at this point, which really should be CCU. So you want to get them to CCU at this point. In terms of the infusion itself, there are different... Drugs that you can use, you can use GTN, you can use isosorbite dinitrate. The actual prescriptions will vary slightly, but you can be guided by that. There will be an infusion guide that you can use with the drug in your particular clinical area. The key is to start at a relatively low level of infusion and titrate the rate up. What you don't want to do is just suddenly drop the blood pressure dramatically. So you need to go relatively steady with these patients and try to keep their systolic blood pressure at least over 90. Start aiming still for that mean arterial blood pressure over 65.
And, yeah, I suppose that is the point. I suppose if you're in A&E, your patient who you thought might have been going to a normal medical bed to a way to troponin or whatever, they're suddenly, like you said, they're going to a CCU, they're going to require that close monitoring. It's a potent vasodilator. Absolutely. And suppose if you're on the ward, straight to somebody senior to get that patient off the ward, an unmonitored ward and on to CCU. Absolutely. Okay, fantastic. So we're treating our patient. We're treating them appropriately. We've got them pain-free. Just thinking sort of further on, what are the complications of the patient's MI? Okay.
So there are a few that we need to think of. You do get your patient who presents with their big anterior MI who's actually in cardiogenic shock and they're tremendously difficult patients to try and manage and really need intensive care support who've got any chance of surviving that initial insult. After the heart attack itself, the things that you'll come across are obviously patients with heart failure. patients with dysrhythmias, whether that be, you'll see ventricular tachycardias, and you'll also see heart blocks. You know, in your patients with inferior anterior MIs, you know, you'll see the second and third degree heart blocks. You get patients who have recurrent infarcts, post-infarct angina, patients with pericarditis, sort of an autoimmune pericarditis, we call it Dressler syndrome, everyone loves an eponymous syndrome. Ventricular septal defects, pretty rarely, and on a similar sort of theme, you can get patients who sort of have acute mitral regurg.
just due to papillary muscle dysfunction or indeed rupture. And actually that can be fatal in quite a lot of occasions in patients who just have torrential regurg and subsequent left heart failure. Okay, so finally Craig, I think we mentioned grade scoring a bit earlier. I think finally she should just mention what that is. Sure. So the GRACE score, again, that's another one of these risk stratification scores. But this is for your patients who do have confirmed acute coronary syndrome. And what we're looking at here is predicting their six-month mortality, because that will impact on the choice of medications that we want to give these patients. And basically, for anyone who has a projected six-month mortality of more than 1.5%, then it's going to recommend giving them clopidogrel. And then for anyone who has that predicted mortality of more than 3%.
These are patients where you're going to consider whether to give them the GP2B3A inhibitors, so this is things like your ticacralor, as a bridge to an inpatient coronary intervention. So again, patients who have the more than 3% predicted six-month mortality, these are patients who should be considered for inpatient coronary intervention within 96 hours, so four days less than that. These are patients who can be managed more safely medically initially and then have further outpatient management either with angiogram or intrusipal stress test. I suppose just finally off the top of my head, I think we mentioned a lot about troponin and raised troponin and things. I think it is worth remembering that other conditions can raise a troponin. I mean, a classic one anecdote I do tell a lot is of a PE that was causing right heart strain, had ECG changes, had SD depression, and had a raised troponin as well. If the patient hadn't suddenly become hypoxic, we might not have thought, well, could this be a PE? So there are other things that can raise a troponin. Sure. I think that is important. I mean, if you want to talk about what the absolute standard definition of a myocardial infarction is,
Yes, you need to have that documented evidence of a raised cardiac biomarker, which for us is troponin. But you also need to have either symptoms or evidence of cardiac ischemia. So either that classical ischemia history or ischemic ECG or anatomical evidence that may be with an echo where you can demonstrate a regional wall motion abnormality as a result of ischemia. I mean, what you're talking about, there are other things that can cause raised troponin. So you mentioned PE is a fairly classical one. You may see it with...
or two dissection. You will see it in patients who have heart failure. You will see it in patients who have chronic renal failure. And you can have type two sort of myocardial injuries as well. So these are where you don't have that sort of primary disruption of an atheromatous coronary plaque. These are patients where you have an increased myocardial oxygen demand or you have a problem of actually delivering oxygen to the myocardium. So your patients with tachydysrithmias, your patients with very severe anemia, or indeed your hypotensive patients, they will sometimes end up with what we call a type two myocardial injury.
Absolutely. I think sometimes with those patients, so you mentioned heart failure and chronic kidney disease with a slightly raged troponin, I know sometimes my seniors advise hold off the ACS stream necessarily and admit for a further troponin, a 12-hour troponin, to check the trend. I think certainly what I would do in that sort of group of patients is that I would do a second troponin measurement three hours after the initial one and look for that, what we would call a sort of delta change. you know, if the patient's got an initially raised level, you know, if it goes up by 20% more on the next level, then I think you can be fairly confident saying, okay, yes, you know, this is an acute coronary event here. That was the Take Orally Acute to Coronary Syndrome podcast. You can find us on Facebook and Twitter, where we'll put up links to guidelines mentioned, and you can contact us to suggest topics you'd like to see covered in future episodes. For more information on education and research opportunities within emergency medicine, acute medicine, and major trauma, you can find NUH Dream on both Facebook and Twitter.